Novus Diagnostics is a leading brand in the field of rapid point-of-care diagnostics for infectious diseases. Our main focus is on Sepsis, a bloodstream infection that claims millions of lives worldwide each year. With our innovative platform, we aim to empower clinicians by providing critical diagnostic information at unparalleled speeds.

Using our patented microfluidic electrochemical sensors and advanced diagnostic algorithms, our platform enables clinicians to confidently tailor treatment in the critical initial stages of triage and treatment. Our bedside test delivers highly accurate results within just 15 minutes, ensuring that patients receive the best therapies right from the outset. One of the key advantages of our technology is the simultaneous diagnosis of infection and classification of the causative pathogen, whether it's gram-negative, gram-positive, or fungal.

This targeted approach allows for rapid infection confirmation and pathogen classification, enabling immediate and tailored treatment in the critical early stages of the disease. Trust Novus Diagnostics to provide clinicians with the tools they need to make informed decisions and ultimately save lives. Contact us today to find out more about our groundbreaking technology